- December 6, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Allergy and immunology » Anaphylaxis
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Allergy and immunology » Anaphylaxis
Background
The potentially fatal acute hypersensitivity reaction known as anaphylaxis is a frequent emergency. It can be characterized as a fast-developing, multi-system, widespread allergic response. Anaphylaxis frequently results in death if untreated because it quickly progresses to pulmonary collapse.
Anaphylactic reactions have traditionally been classified as IgE-based responses, whereas anaphylactoid responses have been classified as IgE-independent occurrences.
Recently, anaphylaxis has been diagnosed using all of these names together. Regardless of the cause, each reaction results in the same stage of the disease and therapy; hence this unified language is today the de facto standard.
Epidemiology
Though the frequency is rising, it is projected that the global population has a higher incidence of between 1% and 3%. Although reactions can happen to people of any age, younger people and developed nations tend to notice them the most.
Anaphylaxis, unfortunately, is frequently incorrectly or never identified. Increased mortality and morbidity are the results of delayed or missed diagnosis.
Anatomy
Pathophysiology
After re-exposure to a particular antigen, basophils and mast cells degranulate, releasing a variety of chemical facilitators, which causes anaphylaxis, which is typically a type 1 IgE-mediated hypersensitivity response.
The fast release of inflammatory mediators that have been stored is caused by IgE linkage and the resulting aggregation of strong affinity receptors. Tryptase, histamine, proteoglycans, and carboxypeptidase A are a few of these inflammatory mediators.
Platelet-activating factors, leukotrienes, and prostaglandins are formed from arachidonic acid by the stimulation of lipoxygenases, phospholipase A, & cyclooxygenases. TNF-alpha, both as a formed & delayed reactant, then mediates the inflammatory reaction.
The following describes the precise physiology of these inflammatory mediators:
Etiology
Exposure to specific drugs, certain meals, and insect bites are examples of common instigating factors. Hyper-acute reactions can result from immunotherapy infusions intended to improve overall allergy reactions.
Latex allergy is becoming more common, and like with other hypersensitivity, there is a danger of anaphylaxis.
Idiopathic anaphylactic is the name given to reactions in which the causative agent is not always known. Alpha-1,3-galactose-induced anaphylaxis is characterized by an IgE antibody reaction.
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
0.1 mg/ml solution
Administer 0.1 mg via intravenous route within 5 minutes at a pace of 1 to 4 mcg/minute to decrease the need for frequent injection dose
1 mg/ml solution
Administer an undiluted drug of 0.3 to 0.5 mg via intramuscular or subcutaneous injection into the front and outer part of the thigh.
Repeat the process every 5 to 10 minutes as required.
prefilled autoinjector or syringe
Administer 0.3 mg intramuscularly or subcutaneously into the front and outer part of the thigh and repeat for 5 to 15 minutes, as necessary.
<30 kg weight:
Administer 0.01 mg/kg of the medication via intramuscular or subcutaneous injection into the front and outer area of the thigh and maximum dose not more than 0.3 mg per vial.
Repeat the dosage every 5 to 10 minutes as required.
≥30 kg weight
Administer 0.3 to 0.5 mg of via intramuscular or subcutaneous injection in the anterolateral region of the thigh and maximum dose not more than 0.5 mg per vial
Repeat the process every 5 to 10 minutes as required.
Future Trends
References
https://www.ncbi.nlm.nih.gov/books/NBK482124/
ADVERTISEMENT
» Home » CAD » Allergy and immunology » Anaphylaxis
The potentially fatal acute hypersensitivity reaction known as anaphylaxis is a frequent emergency. It can be characterized as a fast-developing, multi-system, widespread allergic response. Anaphylaxis frequently results in death if untreated because it quickly progresses to pulmonary collapse.
Anaphylactic reactions have traditionally been classified as IgE-based responses, whereas anaphylactoid responses have been classified as IgE-independent occurrences.
Recently, anaphylaxis has been diagnosed using all of these names together. Regardless of the cause, each reaction results in the same stage of the disease and therapy; hence this unified language is today the de facto standard.
Though the frequency is rising, it is projected that the global population has a higher incidence of between 1% and 3%. Although reactions can happen to people of any age, younger people and developed nations tend to notice them the most.
Anaphylaxis, unfortunately, is frequently incorrectly or never identified. Increased mortality and morbidity are the results of delayed or missed diagnosis.
After re-exposure to a particular antigen, basophils and mast cells degranulate, releasing a variety of chemical facilitators, which causes anaphylaxis, which is typically a type 1 IgE-mediated hypersensitivity response.
The fast release of inflammatory mediators that have been stored is caused by IgE linkage and the resulting aggregation of strong affinity receptors. Tryptase, histamine, proteoglycans, and carboxypeptidase A are a few of these inflammatory mediators.
Platelet-activating factors, leukotrienes, and prostaglandins are formed from arachidonic acid by the stimulation of lipoxygenases, phospholipase A, & cyclooxygenases. TNF-alpha, both as a formed & delayed reactant, then mediates the inflammatory reaction.
The following describes the precise physiology of these inflammatory mediators:
Exposure to specific drugs, certain meals, and insect bites are examples of common instigating factors. Hyper-acute reactions can result from immunotherapy infusions intended to improve overall allergy reactions.
Latex allergy is becoming more common, and like with other hypersensitivity, there is a danger of anaphylaxis.
Idiopathic anaphylactic is the name given to reactions in which the causative agent is not always known. Alpha-1,3-galactose-induced anaphylaxis is characterized by an IgE antibody reaction.
0.1 mg/ml solution
Administer 0.1 mg via intravenous route within 5 minutes at a pace of 1 to 4 mcg/minute to decrease the need for frequent injection dose
1 mg/ml solution
Administer an undiluted drug of 0.3 to 0.5 mg via intramuscular or subcutaneous injection into the front and outer part of the thigh.
Repeat the process every 5 to 10 minutes as required.
prefilled autoinjector or syringe
Administer 0.3 mg intramuscularly or subcutaneously into the front and outer part of the thigh and repeat for 5 to 15 minutes, as necessary.
<30 kg weight:
Administer 0.01 mg/kg of the medication via intramuscular or subcutaneous injection into the front and outer area of the thigh and maximum dose not more than 0.3 mg per vial.
Repeat the dosage every 5 to 10 minutes as required.
≥30 kg weight
Administer 0.3 to 0.5 mg of via intramuscular or subcutaneous injection in the anterolateral region of the thigh and maximum dose not more than 0.5 mg per vial
Repeat the process every 5 to 10 minutes as required.
https://www.ncbi.nlm.nih.gov/books/NBK482124/
The potentially fatal acute hypersensitivity reaction known as anaphylaxis is a frequent emergency. It can be characterized as a fast-developing, multi-system, widespread allergic response. Anaphylaxis frequently results in death if untreated because it quickly progresses to pulmonary collapse.
Anaphylactic reactions have traditionally been classified as IgE-based responses, whereas anaphylactoid responses have been classified as IgE-independent occurrences.
Recently, anaphylaxis has been diagnosed using all of these names together. Regardless of the cause, each reaction results in the same stage of the disease and therapy; hence this unified language is today the de facto standard.
Though the frequency is rising, it is projected that the global population has a higher incidence of between 1% and 3%. Although reactions can happen to people of any age, younger people and developed nations tend to notice them the most.
Anaphylaxis, unfortunately, is frequently incorrectly or never identified. Increased mortality and morbidity are the results of delayed or missed diagnosis.
After re-exposure to a particular antigen, basophils and mast cells degranulate, releasing a variety of chemical facilitators, which causes anaphylaxis, which is typically a type 1 IgE-mediated hypersensitivity response.
The fast release of inflammatory mediators that have been stored is caused by IgE linkage and the resulting aggregation of strong affinity receptors. Tryptase, histamine, proteoglycans, and carboxypeptidase A are a few of these inflammatory mediators.
Platelet-activating factors, leukotrienes, and prostaglandins are formed from arachidonic acid by the stimulation of lipoxygenases, phospholipase A, & cyclooxygenases. TNF-alpha, both as a formed & delayed reactant, then mediates the inflammatory reaction.
The following describes the precise physiology of these inflammatory mediators:
Exposure to specific drugs, certain meals, and insect bites are examples of common instigating factors. Hyper-acute reactions can result from immunotherapy infusions intended to improve overall allergy reactions.
Latex allergy is becoming more common, and like with other hypersensitivity, there is a danger of anaphylaxis.
Idiopathic anaphylactic is the name given to reactions in which the causative agent is not always known. Alpha-1,3-galactose-induced anaphylaxis is characterized by an IgE antibody reaction.
https://www.ncbi.nlm.nih.gov/books/NBK482124/
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.